PDRN Salmon Facial: The Complete Provider & Patient Guide
PDRN has a 40-year history in pharmaceutical wound care and the clinical evidence behind it is stronger than the name suggests. This guide gives aesthetic providers and curious patients a clear, evidence-based look at the science, the protocols, the pricing, and the practical steps for integrating one of 2026’s most requested regenerative treatments into an existing practice with confidence.
What Is PDRN?
PDRN stands for polydeoxyribonucleotide, a purified short-chain DNA fragment extracted from the milt of Oncorhynchus mykiss (rainbow trout) or Oncorhynchus keta (chum salmon) — both gold standards for pharmaceutical PDRN extraction due to their approximately 95% DNA base pair similarity to human DNA. Despite the attention-grabbing origin, the final product is a pharmaceutical-grade compound. The extraction process removes all proteins entirely, leaving only purified nucleotide sequences that are structurally comparable to fragments of human DNA.
Salmon DNA is used specifically because it shares approximately 95% structural homology with human DNA, making it highly biocompatible and minimally immunogenic. The vast majority of patients tolerate it well.
Once in contact with skin tissue, PDRN activates adenosine A2A receptors on fibroblasts and endothelial cells. This receptor-mediated signaling triggers:
- Collagen and elastin synthesis by fibroblasts
- Angiogenesis, or the formation of new blood vessels that improve tissue oxygenation
- Cell proliferation and tissue repair at the site of application
- Tyrosinase inhibition, which reduces melanin production and improves pigmentation
PDRN vs. PN (Polynucleotides): Understanding the Difference
Both compounds are derived from salmon DNA, but they work differently in tissue. Knowing the distinction helps providers evaluate products and counsel patients accurately.
| Property | PDRN | PN (Polynucleotides) |
|---|---|---|
| Fragment length | Short-chain | Long-chain |
| Molecular weight | Lower | Higher |
| Primary action | Cellular repair via A2A receptor activation | Structural scaffolding and tissue support |
| Tissue penetration | Deeper, faster | More superficial |
| Best clinical use | Regeneration, healing, pigmentation correction | Volume support, hydration, skin booster effect |
* Many commercial products blend both PDRN and PN. Always review molecular weight specifications when evaluating suppliers or recommending products to patients. Clinical performance varies by product formulation, concentration, and delivery method.
A History of PDRN: From Wound Care to Medspa
Key milestones:
- 1980s: Italian and South Korean researchers begin studying PDRN as a pharmaceutical-grade agent for wound healing, applying it to diabetic ulcers, pressure sores, and burn injuries
- 1986: Nucleic-acid compounds are used to treat radiation-damaged skin in Chernobyl victims
- 1996: The term “PDRN” is formally introduced and systematic commercialization of pharmaceutical PDRN products begins
- Early 2000s: Injectable PDRN enters aesthetic medicine as peer-reviewed literature begins documenting the A2A receptor mechanism in skin tissue
- ~2014: South Korean brand Rejuran launches as a dedicated aesthetic PDRN injectable, receiving MFDS (Korea FDA) approval and repositioning PDRN as a skin healer rather than a filler
- Late 2010s: K-beauty export culture spreads the treatment to Southeast Asia, the Middle East, and Europe
- 2023 to 2024: The salmon sperm facial goes viral in Western markets through TikTok and mainstream media coverage
- 2025 to 2026: PDRN transitions from novelty trend to established aesthetic offering across U.S. medspas, with combination protocols becoming the standard of care
Clinical Evidence: What the Research Shows
Key studies and findings:
- A 2025 peer-reviewed study published in Aesthetic Medicine found that microneedling combined with 3% PDRN significantly improved overall skin quality and reduced facial hyperpigmentation, with no adverse effects recorded across treated patients
- A 2025 study in PLoS ONE demonstrated that PDRN mitigated UV and oxidative stress-induced cellular aging, prevented the degradation of SIRT1 — the master regulatory protein of cellular aging in skin — by attenuating nuclear autophagy, helping skin cells maintain their repair capacity rather than simply providing a temporary hydration effect, and reduced markers of skin senescence at the cellular level, providing molecular-level support for PDRN’s anti-aging claims
- PDRN has been consistently shown to inhibit tyrosinase, the rate-limiting enzyme in melanin synthesis, providing a mechanistic basis for its effectiveness against hyperpigmentation and uneven skin tone. The same research further found that thermal-denatured PDRN achieves up to 2.3x higher tyrosinase inhibition than standard formulations, though clinical human trials are ongoing to confirm whether these in vitro findings translate directly to patient outcomes.
- An active ClinicalTrials.gov study is currently evaluating PDRN combined with hyaluronic acid and niacinamide for periocular wrinkle reduction, indicating the research pipeline is actively expanding
An honest assessment for providers: The evidence base is compelling and grounded in solid basic science, but it is not yet as deep as treatments like PRP or HA fillers that carry decades of large-scale trial data. PDRN currently sits in a similar evidentiary position to where exosomes were three to four years ago: strong mechanistic rationale, promising clinical outcomes, and an actively growing body of research. The risk of early adoption is low. The risk of late adoption is a competitive one.
How Popular Is PDRN? Market Data and Demand Signals
Market data:
The global polydeoxyribonucleotide injectables market was valued at
$211 million in 2024 and is projected to reach $803 million by 2033 at a 16.2% CAGR. The wider regenerative aesthetics market, encompassing PDRN, exosomes, PRP, and biostimulators, is growing from $15.58 billion in 2025 to a projected $28.88 billion by 2030 at a 13.1% CAGR. Sub-segment analysis from Future Market Insights indicates the U.S. holds a 23.2% global market share in PDRN skincare, with injectables commanding 38.1% of the category and anti-aging indications leading at 30.7%.
What is driving consumer demand:
- Viral social media content has made “salmon sperm facial” one of the most searched aesthetic treatment terms globally
- A documented shift away from the overfilled aesthetic toward skin quality focused results
- Growing patient fatigue with repeat filler appointments and a desire for treatments with cumulative, long-term outcomes
- Celebrity and influencer endorsements bringing the treatment into mainstream awareness in Western markets
What Does PDRN Treat?
- Overall skin quality and luminosity: the glass skin effect most associated with the treatment in K-beauty culture
- Fine lines and early signs of aging: through fibroblast-stimulated collagen and elastin synthesis
- Acne scarring: particularly rolling and boxcar scars, where new collagen formation addresses the dermal deficiency underlying the scar
- Hyperpigmentation and uneven skin tone: via tyrosinase inhibition and cellular repair
- Post-procedure recovery: accelerating healing and optimizing outcomes after laser resurfacing, chemical peels, or ablative treatments
- Skin laxity and texture: particularly effective when combined with microneedling or RF microneedling
- Periocular rejuvenation: PDRN increases dermal thickness in thin-skin areas like the under-eye and crow’s feet zone without the puffiness or migration risk associated with hyaluronic acid fillers — making it one of the most compelling applications for patients who have had poor filler experiences in this area
Treatment Protocols and Delivery Methods
Topical via Microneedling (Most Common in the U.S.)
PDRN serum is applied to the skin during a standard microneedling treatment, penetrating deeply through the microchannels created by the device. This is the most widely available protocol in U.S. practices. It carries no injectable regulatory complexity and can be added to an existing microneedling menu without additional certification in most states.
Typical session: 60 to 90 minutes including numbing time
Downtime: Mild redness and sensitivity for 24 to 48 hours
Recommended series: 3 to 4 sessions spaced 3 to 4 weeks apart, with maintenance every 3 to 6 months
Injectable PDRN (Mesotherapy Protocol)
RF Microneedling with PDRN
Combination Protocols
- PRP, for synergistic growth factor and cellular repair stimulation
- Exosomes, for premium regenerative positioning
- Neurotoxins, as a skin quality complement to a Botox appointment
- Post-laser or post-peel protocols, as a healing accelerator that reduces downtime and optimizes outcomes
Who Is a Good Candidate?
Best candidates:
- Patients aged 30 to 65 concerned with skin quality, texture, or early signs of aging
- Acne scar patients seeking collagen remodeling
- Patients with hyperpigmentation or uneven skin tone
- Post-procedure patients seeking accelerated recovery
- Patients who want regenerative results without volume addition
- Patients who prefer to avoid blood draws (topical protocol only, as an alternative to PRP)
Contraindications to screen at intake:
- Fish or seafood allergy, the most critical contraindication given the salmon-derived source
- Active skin infection or inflammation in the treatment area
- Pregnancy or breastfeeding, due to insufficient safety data
- Active cancer or history of skin cancer, as PDRN’s cell-proliferative properties are a theoretical concern
- Autoimmune conditions, where use should proceed with caution given limited population data
- Blood thinners or anticoagulants, particularly relevant for injectable protocols
Pricing Guide
Patient-Facing Pricing
PDRN Salmon Facial: What Does It Cost?
Pricing reflects current U.S. market rates as of April 2026. Urban and coastal markets typically sit at the higher end of each range. Most providers offer package discounts of 10 to 20% when a series is pre-booked.
| Protocol | Per Session | Series of 3 to 4 Sessions | Package Discount | Best For |
|---|---|---|---|---|
| Topical PDRN Facial PDRN serum applied to skin surface without microneedling | $200 – $400 | $600 – $1,600 | 10 – 15% | Entry-level regenerative skincare; sensitive skin; patients new to the treatment |
| Most Popular Microneedling with PDRN PDRN serum delivered through microneedling channels for deeper penetration | $450 – $900 | $1,350 – $3,600 | 10 – 20% | Acne scarring, anti-aging, skin quality, hyperpigmentation |
| RF Microneedling with PDRN Radiofrequency energy combined with PDRN for tightening and regeneration | $1,000 – $2,200 | $3,000 – $8,800 | 10 – 15% | Skin laxity, deeper wrinkles, mature skin, body areas |
| PDRN Injections — Full Face Mesotherapy-style microinjections across the full face | $500 – $1,200 | $1,500 – $4,800 | 10 – 20% | Patients seeking deeper delivery; glass skin results; where available |
| PDRN Injections — Face and Neck Full face plus neck for comprehensive skin quality improvement | $800 – $1,700 | $2,400 – $6,800 | 10 – 20% | Patients with neck laxity, crepey skin, or sun damage extending below the jawline |
| Combined PDRN with PRP PDRN paired with platelet-rich plasma for synergistic regenerative results | $700 – $1,500 | $2,100 – $6,000 | 10 – 15% | Hair restoration, significant volume loss, post-procedure healing |
| Combined PDRN with Exosomes Premium regenerative stack for maximum skin quality outcomes | $800 – $1,800 | $2,400 – $7,200 | 10 – 15% | High-value patients seeking maximal regenerative results; post-laser recovery |
* Pricing reflects publicly available U.S. market rates as of April 2026 and is subject to change. Individual provider fees vary based on geographic market, provider credentials, treatment duration, and product used. Injectable PDRN protocols are not currently FDA-cleared for aesthetic use in the United States; availability varies by provider and state. For reference, the same treatments in South Korea — where PDRN originated — typically cost $100 to $300 per session. Always confirm current pricing directly with your provider before booking.
For Providers: Overview of Integration Options
PDRN vs. Other Regenerative or Bio-Stimulatory Treatments
How PDRN Compares to Similar Treatments
All five treatments fall under the regenerative or bio-stimulatory category, but they work differently and serve different patient goals. Use this table to guide treatment selection conversations with your provider.
| Feature | PDRN | PRP | Exosomes | HA Fillers | Biostimulators |
|---|---|---|---|---|---|
| Mechanism | Cellular repair via A2A receptor activation | Growth factor release from platelets | Cell signaling via extracellular vesicles | Volume replacement and hydration | Collagen stimulation over time |
| Blood draw required | No | Yes | No | No | No |
| FDA status (U.S.) | Topical: unregulated; Injectable: not cleared | Cleared (device-dependent) | Varies by product | Cleared | Cleared |
| Primary benefit | Skin quality, tissue repair, pigment correction | Healing, hair restoration, mild volume | Regeneration, post-procedure recovery | Immediate volume and contour | Long-term volume and structural support |
| Downtime | Minimal | Mild (24 to 48 hrs redness) | Minimal | Minimal | Minimal |
| Results timeline | Gradual over a series of treatments | Gradual over a series of treatments | Gradual over a series of treatments | Immediate | 3 to 6 months |
| Longevity | 6 to 12 months maintenance | 6 to 12 months | 6 to 12 months | 6 to 18 months | 18 to 24 months |
| Best patient profile | Patients seeking skin quality, texture, and pigment improvement without volume | Patients comfortable with blood draw; hair loss; volume concerns | Post-procedure recovery; advanced regenerative protocols | Patients seeking immediate correction of volume loss or deep lines | Patients with significant collagen loss seeking long-term structural improvement |
* FDA status reflects publicly available regulatory information as of April 2026 and is subject to change. Injectable PDRN is not currently FDA-cleared for aesthetic use in the United States; topical PDRN serums are unregulated cosmetic ingredients. PRP clearance is device-dependent and varies by system. Exosome regulatory status varies significantly by product and manufacturer. Confirm current regulatory status with your provider before proceeding with any treatment. Treatment longevity and results vary by patient, provider, and protocol.
Frequently Asked Questions About PDRN Salmon Facials
A salmon facial, more precisely called a PDRN treatment, is a skin rejuvenation procedure that uses polydeoxyribonucleotide (PDRN), a purified fragment of DNA extracted from salmon sperm. When applied to the skin either topically during microneedling or via injection, PDRN activates the body's own cellular repair mechanisms to stimulate collagen production, improve skin texture, and accelerate tissue healing. Despite the attention-grabbing name, the treatment has a decades-long history in pharmaceutical wound care before becoming an aesthetic procedure.
Yes, but not in the way it sounds. PDRN is derived from the sperm cells of salmon, but it undergoes an extensive purification process that removes all proteins, leaving only short-chain DNA fragments. The final product is a pharmaceutical-grade compound with no biological material other than purified nucleotide sequences. Salmon DNA is used specifically because it shares approximately 95% structural homology with human DNA, making it highly biocompatible and unlikely to trigger an immune response.
PDRN and PN are related but not interchangeable. PN (polynucleotide) refers to longer-chain DNA fragments used primarily for structural scaffolding and tissue volumizing. PDRN refers to shorter, lower-molecular-weight fragments that penetrate tissue more readily and work at the cellular level to trigger receptor-mediated repair. Think of PN as the scaffolding and PDRN as the repair crew. Many products blend both, so it is worth checking the molecular weight specifications when evaluating suppliers or recommending products to patients.
The clinical evidence is promising and growing, though the research base is not yet as extensive as treatments like PRP or hyaluronic acid fillers. Peer-reviewed studies have shown PDRN significantly improves skin texture, reduces hyperpigmentation, and accelerates healing when combined with microneedling, with minimal side effects reported. PDRN's mechanism of action — activating adenosine A2A receptors to stimulate fibroblast activity and collagen synthesis — is well-documented in pharmaceutical literature going back to the 1990s. Most practitioners and patients report visible improvement in skin quality, hydration, and tone after a series of 3 to 4 treatments.
Most protocols recommend an initial series of 3 to 4 sessions spaced 3 to 4 weeks apart, followed by maintenance treatments every 3 to 6 months. Results are cumulative — skin quality improvements build with each session as collagen remodeling progresses. Unlike fillers, which deliver immediate but temporary volume, PDRN results develop gradually and are generally described as lasting 6 to 12 months before a maintenance session is recommended. Individual results vary based on age, skin condition, and the delivery method used.
Pricing varies significantly based on the delivery method and your location. A basic topical PDRN facial runs $200 to $400 per session. Microneedling with PDRN, the most popular combination, typically costs $450 to $900 per session. RF microneedling with PDRN ranges from $1,000 to $2,200 per session, and injectable PDRN protocols where available run $500 to $1,200 per session for the full face. A full initial series of 3 to 4 sessions typically runs between $1,350 and $4,800 depending on the protocol chosen. Most providers offer package pricing with a 10 to 20% discount per session when a series is pre-booked.
This is one of the most important questions for both patients and providers to understand clearly. Topical PDRN serums are legal and widely available in the U.S. and are not subject to FDA drug approval requirements. The most common U.S. protocol — applying PDRN serum during microneedling — falls under existing microneedling scope-of-practice rules, which vary by state. Injectable PDRN, however, is not currently FDA-cleared for aesthetic use in the United States. Products like Rejuran are approved in South Korea and other markets but are used off-label or sourced internationally in the U.S. Providers should consult their state medical board guidelines before offering injectable protocols.
Both PDRN and PRP are regenerative treatments that stimulate the body's own repair mechanisms, but they work differently and have distinct practical profiles. PDRN activates A2A receptors to drive cellular repair, requires no blood draw, and delivers a standardized, consistent product every time. PRP releases growth factors from the patient's own platelets, requires a blood draw, and varies in composition based on the individual patient. PDRN is often preferred by patients who are uncomfortable with blood draws or in practices that want a more predictable product. Many providers are beginning to combine both for synergistic regenerative results.
Yes, and this is one of PDRN's strongest clinical applications. PDRN promotes fibroblast proliferation and new collagen formation in damaged tissue, which directly addresses the dermal deficiency underlying atrophic acne scars. When delivered via microneedling, the mechanical channel creation combines with PDRN's cellular repair signaling for a two-pronged approach to scar remodeling. Multiple sessions are typically needed for significant improvement, and results are best for rolling and boxcar scars rather than deep ice-pick scars.
PDRN is generally well-tolerated, but providers should screen for the following contraindications before proceeding: a fish or seafood allergy (the most important contraindication, as PDRN is salmon-derived), active skin infection or inflammation in the treatment area, pregnancy or breastfeeding due to insufficient safety data, active cancer or a history of skin cancer given PDRN's cell-proliferative effects, autoimmune conditions where use should proceed with caution, and blood thinners or anticoagulants which are particularly relevant for injectable protocols. A simple intake checklist covering these points protects both the patient and the practice.
Not exactly, but PDRN is closely associated with the glass skin aesthetic that originated in Korean beauty culture. Glass skin refers to a complexion that appears smooth, luminous, and almost translucent, and PDRN is one of the treatments most credited with achieving it, particularly when used in a series. In South Korea, PDRN injections are a foundational part of many glass skin protocols, sometimes combined with other skin boosters. In the U.S., the microneedling with PDRN serum combination is the most accessible approximation of that result.
For most aesthetic providers in the U.S., the lowest-friction entry point is the microneedling with PDRN topical protocol, which requires an existing microneedling device and certification, a pharmaceutical-grade PDRN serum from a reputable supplier with verified molecular weight specs and purity documentation, a simple patient intake form covering contraindications, and updated consent and treatment documentation. No additional certification is required for the topical route in most states. The topical add-on can be priced as a premium upgrade to your existing microneedling menu, typically adding $150 to $400 in revenue per session with a product cost of $30 to $80. IAPAM members can access our full Provider Implementation Guide for complete protocols, fee schedule frameworks, and a ready-to-use intake checklist.
Download Your Free Botox Best Practices Guide
Discover proven techniques and industry insights to elevate your aesthetic practice. This comprehensive ebook covers essential protocols, patient safety, and advanced injection strategies used by top practitioners.
- Mattioli-1885 Journals. Comparison of microneedling and polydeoxyribonucleotide salmon 3% vs. microneedling and PRP for facial rejuvenation: a randomized controlled trial. Aesthetic Medicine. 2025. Comparison of microneedling and PDRN salmon 3% vs. microneedling and PRP
- Mattioli-1885 Journals. Efficacy of microneedling with PDRN salmon 3% to reduce facial hyperpigmentation. Aesthetic Medicine. 2025. Efficacy of microneedling with PDRN salmon 3% to reduce facial hyperpigmentation
- PLoS ONE. PDRN prevents SIRT1 degradation by attenuating autophagy during skin aging. PLoS ONE. 2025. PDRN prevents SIRT1 degradation by attenuating autophagy during skin aging
- National Library of Medicine. PDRN prevents SIRT1 degradation by attenuating autophagy during skin aging. PubMed. 2025. PDRN prevents SIRT1 degradation — PubMed abstract
- Spandidos Publications. Thermal-denatured PDRN exhibits increased in vitro tyrosinase inhibition and reduced cellular melanin content. Experimental and Therapeutic Medicine. 2025. Thermal-denatured PDRN exhibits increased tyrosinase inhibition
- National Library of Medicine. Novel anti-melanogenesis properties of polydeoxyribonucleotide: possible implications in skin health. PMC. 2016. Novel anti-melanogenesis properties of polydeoxyribonucleotide
- ClinicalTrials.gov. Regenerative treatment of periocular wrinkles with PDRN (NCT07280637). U.S. National Library of Medicine. 2025. Regenerative treatment of periocular wrinkles with PDRN
- Research and Markets. Polydeoxyribonucleotide injectables market forecast to 2033. 2024. Polydeoxyribonucleotide injectables market forecast to 2033
- Research and Markets. Regenerative aesthetics market report 2026. 2025. Regenerative aesthetics market report 2026
- Future Market Insights. PDRN skincare market report 2025 to 2035. 2025. PDRN skincare market report 2025 to 2035
- Grand View Research. Polydeoxyribonucleotides (PDRN) skin boosters market data. 2025. Polydeoxyribonucleotides (PDRN) skin boosters market data
- Skin Spa New York. PDRN salmon DNA facials: the complete science behind results in 2026. 2026. PDRN salmon DNA facials: the complete science behind results in 2026
- Skin Spa New York. Understanding PDRN salmon DNA facials: the science behind regenerative skincare in 2026. 2026. Understanding PDRN salmon DNA facials: the science behind regenerative skincare in 2026
- Sparrow MD. The science behind PDRN: how salmon DNA works. 2025. The science behind PDRN: how salmon DNA works
- Honey Skincare Studio. The medical origins of PDRN: from wound healing to skin rejuvenation. 2025. The medical origins of PDRN: from wound healing to skin rejuvenation
- LinkedIn / K-Beauty Science Inc. Decoding PDRN (1): the history of PDRN. 2026. Decoding PDRN (1): the history of PDRN
- Vivacy. Rejuran: Korea’s leading PN skin booster and regeneration. 2026. Rejuran: Korea’s leading PN skin booster and regeneration
- Charette Cosmetics. Salmon DNA pricing and average cost. 2025. Salmon DNA pricing and average cost
- Empire Medical Training. Salmon sperm facials: costs and benefits of this Korean skincare trend. 2026. Salmon sperm facials: costs and benefits
- Personal Care Insights. Salmon sperm facials trend as consumers seek natural alternatives. 2025. Salmon sperm facials trend as consumers seek natural alternatives
- SingDerm. Why salmon-derived PDRN is becoming a global trend in regenerative aesthetics. 2025. Why salmon-derived PDRN is becoming a global trend in regenerative aesthetics
- Majorcosmeticals. The great shift of 2026: from volumization to bio-regeneration in aesthetic injectables. 2026. The great shift of 2026: from volumization to bio-regeneration in aesthetic injectables